Future investigations should leverage the pleiotropy of GLP-1RAs to evaluate their effectiveness in treating multimorbidities, rather than focusing on a single health condition, particularly where obesity or other mechanistic pathways affected by GLP-1RAs are leading drivers, the authors write in their paper
Diabetic retinopathy warrants particular attention, especially in patients with type 2 diabetes
[DOI] [PubMed] [Google Scholar] 211.Featherstone R.E., Kapur S., Fletcher P.J
They were originally developed to treat type 2 diabetes as they improve the body's ability to respond to dietary sugars with the hormone insulin, but they can also be prescribed for weight loss
1998) to compensate for tissue motion (e.g., due to respiration and heartbeat) in the recorded time series
Book your free consultation todaylet us help you prioritise your health and wellbeing with a personalised treatment plan